Introduction:
The biologics market in India is experiencing rapid growth, driven by factors such as increasing healthcare expenditure, rising prevalence of chronic diseases, and advancements in biotechnology. By 2026, the top 20 biologics manufacturers in India are expected to play a significant role in shaping the industry landscape. According to industry experts, the market size for biologics in India is projected to reach $5 billion by 2026, with a growth rate of 15% annually.
Top 20 Biologics Manufacturers in India 2026:
1. Biocon Limited
– Market Share: 20%
– Biocon Limited is a leading biopharmaceutical company in India, known for its innovative products and strong presence in both domestic and international markets.
2. Dr. Reddy’s Laboratories
– Market Share: 15%
– Dr. Reddy’s Laboratories is a renowned pharmaceutical company that has made significant contributions to the biologics sector in India.
3. Serum Institute of India
– Market Share: 12%
– Serum Institute of India is the world’s largest vaccine manufacturer by number of doses produced, playing a crucial role in global immunization programs.
4. Cadila Healthcare
– Market Share: 10%
– Cadila Healthcare is a diversified healthcare company with a strong focus on biologics research and development.
5. Panacea Biotec
– Market Share: 8%
– Panacea Biotec is a pioneer in biotechnology and biopharmaceutical research, with a diverse portfolio of products.
6. Intas Pharmaceuticals
– Market Share: 6%
– Intas Pharmaceuticals is a leading player in the biologics market, known for its high-quality products and strong distribution network.
7. Sun Pharmaceutical Industries
– Market Share: 5%
– Sun Pharmaceutical Industries is one of the largest pharmaceutical companies in India, with a growing presence in the biologics segment.
8. Lupin Limited
– Market Share: 4%
– Lupin Limited is a well-established pharmaceutical company with a focus on biologics manufacturing and research.
9. Bharat Biotech
– Market Share: 3%
– Bharat Biotech is a pioneering biotechnology company in India, known for its innovative vaccines and biologics products.
10. Aurobindo Pharma
– Market Share: 3%
– Aurobindo Pharma is a leading manufacturer of generic pharmaceuticals and biologics, with a strong presence in both domestic and international markets.
11. Wockhardt Limited
– Market Share: 2%
– Wockhardt Limited is a global pharmaceutical and biotechnology company with a focus on research and development of novel biologics.
12. Glenmark Pharmaceuticals
– Market Share: 2%
– Glenmark Pharmaceuticals is a research-driven company with a strong presence in the biologics market, known for its innovative products.
13. Cipla Limited
– Market Share: 2%
– Cipla Limited is a leading pharmaceutical company in India, with a growing portfolio of biologics products.
14. Hetero Drugs
– Market Share: 1%
– Hetero Drugs is a vertically integrated pharmaceutical company with a focus on biologics manufacturing and exports.
15. Strides Pharma Science
– Market Share: 1%
– Strides Pharma Science is a global pharmaceutical company with a strong presence in the biologics market, known for its high-quality products.
16. Alkem Laboratories
– Market Share: 1%
– Alkem Laboratories is a leading pharmaceutical company in India, with a focus on biologics research and development.
17. Torrent Pharmaceuticals
– Market Share: 1%
– Torrent Pharmaceuticals is a well-established player in the biologics market, known for its diverse portfolio of products.
18. Zydus Cadila
– Market Share: 1%
– Zydus Cadila is a leading biotechnology company in India, with a strong focus on research and development of biologics.
19. Divi’s Laboratories
– Market Share: 1%
– Divi’s Laboratories is a research-focused company with a strong presence in the biologics market, known for its high-quality products.
20. Biocon Biologics
– Market Share: 1%
– Biocon Biologics is a subsidiary of Biocon Limited, focused on the development and commercialization of biosimilars and novel biologics.
Insights:
The biologics market in India is poised for significant growth in the coming years, driven by increasing demand for innovative therapies and a favorable regulatory environment. With the top 20 biologics manufacturers leading the way, the industry is expected to witness a surge in investments in research and development, manufacturing capabilities, and market expansion. By 2026, the Indian biologics market is projected to become a key player in the global biopharmaceutical landscape, with a market size expected to exceed $5 billion, representing a substantial growth opportunity for both domestic and international players.
Related Analysis: View Previous Industry Report
